Latest in News & Research
FDA Approves EBGLYSS for Moderate-to-Severe Atopic Dermatitis in Adults and Adolescents
The IL-13 inhibitor offers a new first-line biologic treatment option for moderate-to-severe atopic dermatitis not well-controlled with topicals
Remote Cutaneous Confocal Microscopy Has Good Diagnostic Accuracy for Skin Malignancy
Sensitivity of remote CCM was 89 percent, specificity was 64 percent for detection of malignancy
Superior Drug Survival Seen for Dupilumab in Pediatric Patients With AD
Risk for drug discontinuation higher due to ineffectiveness, adverse events for MTX, CsA versus dupilumab
Relationship Suggested Between Hyperhidrosis, Sensitive Skin
Sensitive skin occurred on body sites that were and were not affected by hyperhidrosis
Benzene Exposure Results From Benzoyl Peroxide Drug Product Use
Benzene concentrations detected in 111 over-the-counter BPO drug products that were tested, maintained at room temperature
Risk for Second Melanoma Up for Those With First Melanoma Diagnosis
Melanoma less common among racial and ethnic minorities, but they still have increased rate of second primary melanoma
Disease-Specific Survival Equal for Mohs, Wide Local Excision in Cutaneous Leiomyosarcoma
DSS similar with Mohs micrographic surgery, wide local excision treatment; findings persist in adjusted analysis
Serum, Tissue Levels of CXCL9 Elevated in Nonsegmental Vitiligo
Serum and tissue levels of CXCL9 are reduced after 12 weeks of narrowband ultraviolet B phototherapy
Bimekizumab Safe, Efficacious Over Two Years for Hidradenitis Suppurativa
Clinically meaningful efficacy outcomes observed at one year maintained to two years of treatment
Long-Term Efficacy for Lebrikizumab Seen in Moderate, Severe Eczema
Long-term efficacy seen for lebrikizumab every two weeks or every four weeks in moderate-to-severe atopic dermatitis
Anti-CTAg Antibodies Identified in Stage I, II Melanoma
Specific antibodies against three tumor antigens identified as promising diagnostic biomarkers for early-stage melanomas
Incidence of Epidermal Necrolysis 2.6 Cases Per Million Person-Years
Factors associated with in-hospital mortality include age, history of cancer, dementia, liver disease, EN severity
AI Model Exhibits Diagnostic Bias Towards Fitzpatrick I to III Subgroup
VisualDX demonstrated significantly greater sensitivity for Fitzpatrick I to III subgroup than Fitzpatrick IV to VI and a processed image subgroup
Home-Based Phototherapy as Effective as Office-Based for Psoriasis
For plaque or guttate psoriasis, home-based phototherapy noninferior to office-based phototherapy for PGA and DLQI
Melanoma Risk Increased After Radioactive Iodine Treatment for Primary Thyroid Cancer
Standardized incidence ratios elevated for all nonkeratinocyte skin cancers, melanoma
Semaglutide Beneficial for Hidradenitis Suppurativa in Patients With Obesity
Semaglutide added to standard treatments yields improvement in quality of life, reduction in flares
Robotic Hair Transplant Technology ARTAS Found to Be Safe, Effective
Total yield rate lower, but not significantly so, on ARTAS side, and total transection rate also lower
Multiple Methods ID Anatomic Location of Nonmelanoma Tumor When Location Uncertain
When the precise location of a nonmelanoma tumor is uncertain, surgeons consider multiple elements of available data
Long-Term Survival Benefit Seen for Nivolumab in Advanced Melanoma
Continued survival benefit seen for nivolumab plus ipilimumab and for nivolumab monotherapy versus ipilimumab monotherapy
FDA Approves Ebglyss for Moderate-to-Severe Atopic Dermatitis
Approval is for new, first-line biologic treatment of eczema that is not well controlled with topicals in people 12 years and older
Once-Daily Roflumilast Cream Improves Atopic Dermatitis
Primary end point achieved by significantly more patients treated with roflumilast versus vehicle cream
Cutaneous Head, Neck Melanoma Has Distinct Clinicopathological Profile
Worse locoregional control, distant metastasis-free survival seen for CHNM versus cutaneous melanoma of other sites
Study Looks at Sex Differences in Melanoma Incidence
Melanoma incidence highest on trunk in men; incidence historically highest on limbs in women, but recent increases seen in truncal melanoma
24 of 1238